Table 2.
Characteristics of children with COVID-19
| # Studies | # Patients | N (%) | |
|---|---|---|---|
| Underlying conditions | 20 | 665 | 233(35.6) |
| Immunosuppression | 71(30.5) | ||
| Respiratory | 49(21.0) | ||
| Cardiovascular | 32(13.7) | ||
| Medically complex/congenital malformations | 25(10.7) | ||
| Not reported | 17(7.3) | ||
| Hematologic | 8(3.8) | ||
| Neurologic | 8(3.4) | ||
| Obesity | 8(3.4) | ||
| Prematurity | 5(3.4) | ||
| Endocrine/metabolic | 5(2.1) | ||
| Renal | 4(1.7) | ||
| Gastrointestinal | 5(3.4) | ||
| Co-infections | 35 | 1183 | 72(5.6) |
| Bacterial | |||
| Mycoplasma pneumoniae | 42(58.3) | ||
| Enterobacter sepsis | 2(2.8) | ||
| Streptococcus pneumoniae Viral | 1(1.4) | ||
| Influenza virus A/B | 8(11.1) | ||
| Respiratory syncytial virus | 7(9.7) | ||
| Cytomegalovirus | 3(4.2) | ||
| Epstein-Barr virus | 3(4.2) | ||
| Adenovirus | 2(2.8) | ||
| Human metapneumovirus | 2(2.8) | ||
| Human parainfluenza virus | 2(2.8) |